Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-005481
Filing Date
2019-04-16
Accepted
2019-04-16 16:49:32
Documents
67
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1927987
2 ex10-59.htm EX-10.59 51863
3 ex21-1.htm EX-21.1 4413
  Complete submission text file 0001493152-19-005481.txt   5333447

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE imun-20181231.xml EX-101.INS 681592
5 XBRL SCHEMA FILE imun-20181231.xsd EX-101.SCH 55942
6 XBRL CALCULATION FILE imun-20181231_cal.xml EX-101.CAL 62242
7 XBRL DEFINITION FILE imun-20181231_def.xml EX-101.DEF 183312
8 XBRL LABEL FILE imun-20181231_lab.xml EX-101.LAB 337986
9 XBRL PRESENTATION FILE imun-20181231_pre.xml EX-101.PRE 279137
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

EIN.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54933 | Film No.: 19751428
SIC: 2834 Pharmaceutical Preparations